---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-058837"
form_type: "8-K/A"
ticker: "JAGX"
cik: "0001585608"
company_name: "Jaguar Health, Inc."
filed_at: "2025-04-25T23:59:59+00:00"
generated_at: "2026-05-23T05:51:32.890556+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Jaguar Health extends note maturity to July 2025, reduces royalty balance by $1.09M via stock

## Summary
- Issued 1,290,000 shares to a royalty holder in exchange for $1,094,952 reduction in outstanding royalty balance.
- Entered Note Amendment with Streeterville Capital extending $6,220,812.50 secured promissory note maturity to July 20, 2025.
- Note Amendment dated January 29, 2025, includes wholly-owned subsidiary Napo Pharmaceuticals as co-borrower.
- Shares issued in the exchange rely on Section 3(a)(9) exemption from registration.

## SEC filing metadata
- accession: 0000950170-25-058837
- form_type: 8-K/A
- ticker: JAGX
- cik: 0001585608
- company_name: Jaguar Health, Inc.
- filed_at: 2025-04-25T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.02, 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1585608/000095017025058837/0000950170-25-058837-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1585608/000095017025058837/jagx-20250129.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-058837
- JSON: https://secwatch.observer/filing/0000950170-25-058837.json
- Plain text: https://secwatch.observer/filing/0000950170-25-058837.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.